■ Are you an intellectual property attorney in need of scientific expert witnesses and/or laboratory testing to support patent litigation?

■ Are you seeking the testimony of seasoned hands-on industry executives regarding manufacturing and commercialization of generic drugs for an antitrust case?

■ Are you a pharmaceutical scientist seeking help in solving a formulation or manufacturing problem affecting product quality?

We offer comprehensive services to address these and many other issues.


3D-legal-clipart--illustration-000039737352_MEDOur senior experts have been involved in pharmaceutical IP litigation for over 15 years, and have participated in numerous cases involving patent invalidity and infringement. Clients have included developers and manufacturers of both branded and generic products.

Available services include:

  • Scientific strategy consulting
  • Identification and referral of the most capable experts
  • Expert witness testimony
  • Literature searches
  • Laboratory testing at one of our six partner universities and specialty labs
  • Project management

Recent cases have typically included one or more expert witnesses supported by a laboratory team with assistance from additional team members performing documentation and literature search services, and managed by an Acumen BioPharma project manager.

Most of our cases were settled out of court and their records remain confidential, preventing Acumen BioPharma from describing our role in those cases (attorney references available on request). However, two high-profile cases in which Acumen BioPharma participated and that were litigated to completion have been the Oxycodone 2013 and 2014 cases in NY federal court. Links to the Judge Alfred Stein decisions in both cases can be found in the links below.


Antitrust laws also referred as “competition laws” are intended to ensure that there is fair competition in an open-market economy to protect consumers. This is not protection from competition, but instead through competition, the antitrust laws serve as a core component of U.S. economic policy. Intellectual Property litigation between the innovator product (branded) company and generic manufacturers with PIV filings may end in settlements between the players that may potentially infringe antitrust laws. Some types of pharmaceuticals antitrust cases include:

  • Reverse payment or pay-for-delay
  • “Product hopping” through the introduction of new versions of brand name products facing generic competition
  • Drug product price fixing practices

Our industry leading experts have extensive experience in pre and post pharmaceutical product Life Cycle Management and Loss of Exclusivity (LOE) strategies, as well as commercialization of PIV and 505 B2 generics. The cross functional operational team has been closely involved in the planning and execution of generic and branded product launches including:

  • Regulatory compliance
  • Manufacturing site readiness strategies
  • Inventory management
  • Product pricing
  • Market access strategies

Our hands-on consultants provide objective and thorough analysis of data to support clients in the assessment of the industry practices and procedures applied by the parties of the antitrust litigation. All service follows Acumen principles and values that are built on the highest level of integrity and objectivity.


intellectual-property-MEDOur services in this area focus on proactive management of IP issues. We help innovators to identify opportunities for developing IP. This includes analyses of the patent landscape, identification of opportunities for innovative development, help in articulating inventive concepts, and critical analysis of patent language to identify and mitigate weaknesses, resulting in stronger patents.

We also help clients determine whether they are infringing a patent (or whether a competitor is infringing their patent) by performing a technical analysis of the accused product, method, or process relative to the relevant patents.

Also, we advise clients that seek to minimize the probability of infringing an existing patent. This includes an analysis of the scope of existing patents, and identification of product design methodologies that reduce the probability of infringement (whether literally, or under doctrine of equivalents).

Interested in learning more about OUR SERVICES?


  • “Acumen BioPharma has been instrumental for my practice in intellectual property litigation in the identification of cutting edge technology to conduct scientific analysis. Acumen's process emphasizes detailed coordination focused on customer deadlines.”
    - Patent Litigator, Washington DC
  • “As a patent litigator involved in Hatch Waxman related cases, I have been very satisfied with the excellence of services and consistent timely delivery received from Acumen BioPharma.  Acumen brings together top scientists from different disciplines in pharmaceutical manufacturing technology to conduct in-depth scientific assessment of patents and provide technical advice based on solid scientific grounds.  ”
    - Patent litigator, California based law firm
  • “ In my patent litigation practice, Acumen has consistently been able to provide excellent technical advice, comprehensive laboratory testing services (including re-creation of critical prior art examples) and has done so on very challenging timelines.”
    - Patent litigator, major New York area law firm


  • A strong network of top academic and industry scientists

  • World-leading research programs in pharmaceutical processing, manufacturing, powder technology, and other critical topics

  • Extensive experience in pharmaceutical regulations